«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:

21卷

期数:

2015年02期

页码:

164-167

栏目:

临床医学

出版日期:

2015-03-20

文章信息/Info

Title:

 Comparsion of clinical effects between tigecycline and carbapenems in treatment of infections caused by multidrugresistant Acinetobacter baumannii

文章编号:

1006-8147（2015）02-0164-04

作者:

张德林¹; 李忠廉²; 张西波²

（1.天津医科大学研究生院，天津 300070；2.天津市南开医院肝胆外科，天津 300100）

Author(s):

ZHANG De-lin[1]; LI Zhong-lian²; ZHANG Xi-bo²

 

(1.Graduate School, Tianjin Medical University，Tianjin 300070，China；2．Department of Hepatobiliary Surgery，Tianjin Nankai Hospital，Tianjin 300100，China)

关键词:

 ; 替加环素; 多重耐药鲍曼不动杆菌; 抗菌药物; 腹腔感染

Keywords:

 ; tigecycline;  multidrugresistant Acinetobacter baumannii;  antibacterial agents;  abdominal infection

分类号:

R63

DOI:

-

文献标志码:

A

摘要:

目的：观察替加环素治疗多重耐药鲍曼不动杆菌（MDRAB）感染的临床疗效。方法：选取78例腹腔手术术后发生多重耐药鲍曼不动杆菌感染的临床病例作为观察对象，分为碳青霉烯类抗生素组（A组）40例、替加环素组（B组）38例；治疗疗程平均2周。每组患者在年龄、性别、基础疾病等方面差异无统计学意义。观察2组患者的细菌学疗效、临床疗效的变化以及安全性评价。结果：A组临床有效率57.50%，细菌清除率52.50%；B组临床有效率71.05%，细菌清除率68.42％，A、B两组组间比较、组内比较差异有统计学意义（P<0.05）。两组均未出现严重不良反应。结论:替加环素对MDRAB导致感染具有良好的临床疗效及安全性，可作为此类细菌感染临床用药的选择。

Abstract:

Objective: To observe the clinical efficacy of tigecycline in treatment of infections caused by multidrugresistant acinetobacter baumannii. Methods: A total of 78 cases of abdominal infections caused by multidrugresistant Acinetobacter baumannii were retrospectively studied.The patients were divided into the carbapenems group (group A) of 40 cases and the tigecycline group (group B) of 38 cases; The course were about 2 weeks on average. No statistical difference in the age, gender, or underlying diseases between the two groups;the bacteriological effect,the therapeutic effect and safety evaluation were observed and compared between the two groups. Results: The clinical effective rate was 57.50%in the carbapenems group and 71.05% in the tigecycline groups. The bacterial eradication rate was 49.51% in the carbapenems group and 68.37% in the tigecycline groups.The differences between the two groups were significant.The severe adverse reactions were not discovered in the two groups. Conclusion: The tigecycline can achieve good clinical therapeutic effect on abdominal infections caused by multidrugresistant Acinetobacter baumannii and could be promoted in the hospital.

参考文献/References:

[1]Koomanachai P ,Tiengrim S,Kiratisin P, et al. Efficacy and safety of colistin (colistimethate sodium)for therapy of infections caused by multidrugresistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital,Bangkok, Thailand[J].Int J Infect Dis,2007,11(5):402

[2]陈佰义,何礼贤,胡必杰,等.中国鲍曼不动杆菌感染诊治与防控专家共识[J].中国医药科学,2012,92(8):3

[3]郝成飞,孙兰菊,李忠廉.胆道感染病原菌对抗菌药物的敏感性分析研究[J].中华医院感染学杂志,2011,21(1):128

[4]佚名.抗菌药物临床研究指导原则[J].中国临床药理学杂志,1987,2(2):126-130

[5]磨国鑫,余丹阳,陈良安.多重耐药鲍氏不动杆菌的药物治疗[J].中华医院感染学杂志,2010,20(8):1195

[6]周秀珍,刘建华,王艳玲,等.鲍曼不动杆菌连续12年的感染分布及耐药性动态变迁[J].中国临床药理学杂志,2011,27(10):755

[7]NNIS System.National nosocomial infections surveillance (NNIS) system report, data summary from January 1992 through June 2003, issued August 2003[J].Am J Infect Control,2003,31(8):481

[8]甘露,邹英,吴昊,等.肝胆外科术后患者腹腔感染耐碳青霉烯类鲍曼不动杆菌临床因素分析[J].国际检验医学杂志,2013,34(24):3277

[9]李春,王中新,沈继录.鲍曼不动杆菌对碳青霉烯类耐药机制研究进展[J].国外医药:抗生素分册,2009,30(2):54

[10]杨均均,黄文祥,史芳静,等.耐碳青霉烯鲍曼不动杆菌流行特征及耐药基因分析[J].中国抗生素杂志,2012,37(5):343

[11]Peleg A Y,Seifert H,Paterson D L.Acinetobacter baumannii: emergence of a successful pathogen[J].Clin Microbiol Rev,2008,21(3):538

[12]Buccoliero G,Morelli E,Lonero G, et al.Rapid spread of multiresistant Acinetobacter baumannii isolates in intensive care units (ICUs) and in vitro activity of colistin and tigecycline[J].Infez Med,2012,20(4):296

[13]Ozbek B,Mataraci E.In vitro effectiveness of colistin, tigecycline and levofloxacin alone and combined with clarithromycin and/or heparin as lock solutions against embedded Acinetobacter baumannii strains[J].J Antimicrob Chemother,2013,68(4):827

相似文献/References:

[1]张 茜,李洪发,刘俊玲,等. 快速扩弓后牙齿及牙槽骨变化的锥体束CT研究[J].天津医科大学学报,2014,20(01):57.
　ZHANG Qian,LI Hong- fa,LIU Jun-ling,et al. Study on cone beam computed tomography study of tooth and alveolar bone changes after rapid maxillary expansion treatment [J].Journal of Tianjin Medical University,2014,20(02):57.
[2]马长辉,杨万松.血清丙氨酸转氨酶与ST段抬高型心肌梗死的相关性研究[J].天津医科大学学报,2014,20(02):116.
　MA Chang-hui,YANG Wan-song.Clinical study of serum alanine aminotransferase in patients with acute ST-segment elevation myocardial infarction[J].Journal of Tianjin Medical University,2014,20(02):116.
[3]李 颖 综述,夏 天 审校. 肥胖相关性肾病的研究进展[J].天津医科大学学报,2014,20(02):165.
[4]牛 健,于晓旭,李 雪,等.重组 CARDs TX 融合蛋白的表达纯化与复性[J].天津医科大学学报,2014,20(03):184.
　NIU Jian,YU Xiao-xu,LI Xue,et al.Expression, purification and renaturation of recombinant CARDs TX fusion protein[J].Journal of Tianjin Medical University,2014,20(02):184.
[5]陈清刚,钱 明,王 毅,等.首发精神分裂症患者与超高危人群认知功能的对照研究[J].天津医科大学学报,2014,20(03):216.
　CHEN Qing gang,QIAN Ming,WANG Yi,et al.Control study of cognitive function in ultra-high risk population of schizophrenia and first-episode schizophrenia patients[J].Journal of Tianjin Medical University,2014,20(02):216.
[6]单立新,高 越,王学菊.血清Cys C、RBP、尿mALb/ Cr检测在糖尿病肾病早期诊断中的价值[J].天津医科大学学报,2014,20(03):241.
[7]班新超,孙保存,谷彦军,等. CXCR4和CathepsinD在恶性纤维组织细胞瘤中的表达及意义[J].天津医科大学学报,2014,20(04):264.
　BAN Xin-chao,SUN Bao-cun,GU Yan-jun,et al.Expression of CXCR4 and CathepsinD in malignant fibrous histiocytoma and their biological significance[J].Journal of Tianjin Medical University,2014,20(02):264.
[8]谭艳萍,吴校伟,刘 寅,等. 冠心病合并糖尿病患者药物涂层支架术后观察[J].天津医科大学学报,2014,20(05):414.
[9]叶剑飞 综述. microRNAs与肿瘤研究的新进展[J].天津医科大学学报,2014,20(05):416.
[10]李 姗,严海泓,章 萍,等. 长春新碱致双手麻木与麻痹性肠梗阻1例报道[J].天津医科大学学报,2014,20(05):373.

备注/Memo

备注/Memo:

 作者简介 张德林（1986-），男，硕士在读，研究方向：中西医结合肝胆外科临床研究；通信作者：李忠廉，E-mail：lizhonglian@medmail.com.cn。

常用功能

更新日期/Last Update: 2015-03-24